Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson’s disease (PD_Manager): study protocol for a pilot randomised controlled trial

Autor: Antonini, A1, 2, Gentile, G2, Giglio, M2, Marcante, A1, Gage, H3, Touray, Mml4, Fotiadis, Di5, Gatsios, D5, Konitsiotis, S6, Timotijevic, L7, Egan, B7, Hodgkins, C7, Biundo, R2, Pellicano, C, Hatzakis, H, Correia Jesuino, Jorge, Antonini, A, Marcante, A, Biundo, R, Gentile, G, Manuela, G, Weis, L, Chiarot, M, Zanin, V, Seljak, Bk, Cestnik, B, Aleksovski, D, Miljkovic, D, Novak, F, Bohanec, M, Anzic, T, Podpecan, V, Valmarska, A, Papa, G, Blazica, B, Boshkoska, Bm, Vilzmann, R, Assogna, F, Spalletta, G, Pellicano, Gr, Palma, V, Scudellari, C, Soru, T, Napoletano, ANTONELLO MARIO, Fanciulli, F, Raffaelli, M, Banks, THOMAS ALLEN, Elliot, B, Hodgkins, C, Seiss, E, Gage, H, Timotijevic, L, Egan, B, Rusconi, P, Peacock, M, Gillies, S, Puttock, E, Touray, Mml, Gatsios, D, Rigas, G, Fotiadis, D, VON FALKENHAUSEN, VERA CHARLOTTE, Uceda, J, Mascato, Sv, de la Cal JR, Olmedo, Jjs, Martinez, F, Arrendondo, Mt, Cikajlo, I, Peterlin-Potisk, K.

Publikováno v: Trials, Vol 19, Iss 1, Pp 1-11 (2018)
Trials

Background Parkinson’s disease is a degenerative neurological condition causing multiple motor and non-motor symptoms that have a serious adverse effect on quality of life. Management is problematic due to the variable and fluctuating nature of sym

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::269f6a47d617b38281051c0f2cfa1078
http://link.springer.com/article/10.1186/s13063-018-2767-4